Description:ASP-3026, with the CAS number 1097917-15-1, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is primarily investigated for its role as a selective inhibitor of certain enzymes or pathways involved in disease processes. The compound's structure typically features specific functional groups that contribute to its biological activity and selectivity. ASP-3026 has been studied for its efficacy in treating conditions such as cancer, where it may target specific tumor types or mechanisms of resistance. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), are crucial for determining its suitability as a therapeutic agent. Additionally, safety and toxicity profiles are essential considerations in the development of ASP-3026, as they influence dosing regimens and potential side effects. Ongoing research aims to elucidate its full therapeutic potential and optimize its use in clinical settings.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]p…](https://static.cymitquimica.com/products/IN/thumb/DA008TDJ.jpg)
